Open original FDA record ↗Recall record
- FDA identifier
- Z-1621-2021
- Company in FDA record
- Boston Scientific Corporation
- FDA record creation date
- May 18, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
One batch of the ELUVIATM Drug Eluting Vascular Stent System incorrect placement of some 6x40mm ELUVIA stents into 6x100mm packaging.
Source facts
- Action
- On April 21, 2021 the firm sent a letter to its customers with Immediate Action Required with the following instructions: If you identify any product from the listed batch within your inventory, please segregate the product immediately and return it to Boston Scientific in accordance with the enclosed instructions. You will receive replacement product for all removed product returned to Boston Scientific. If you are a distributor, please note that the removal depth is to the hospital level and the removal notification should be forwarded to your customers.
- Initiated
- 2021-04-21
- Root cause
- Reprocessing Controls
- Terminated
- 2023-08-07
- Distribution
- US Nationwide distribution in the states of AL, AR, AZ, CA, DE, HI, IL, KS, KY, MA, MD, NC, NJ, NV, NY, OH, OK, PA,PR, TX, VA,WA,WV.
- Recall number
- Z-1621-2021
- Recall status
- Terminated
- CDRH record ID
- 187223
- FDA record created
- 2021-05-18
- Recall event number
- 87839